DK456886D0 - Stabile frysetaerrede praeparater af et anticancer platinkompleks - Google Patents

Stabile frysetaerrede praeparater af et anticancer platinkompleks

Info

Publication number
DK456886D0
DK456886D0 DK456886A DK456886A DK456886D0 DK 456886 D0 DK456886 D0 DK 456886D0 DK 456886 A DK456886 A DK 456886A DK 456886 A DK456886 A DK 456886A DK 456886 D0 DK456886 D0 DK 456886D0
Authority
DK
Denmark
Prior art keywords
anticancer
stable freeze
treated preparations
platin
complex
Prior art date
Application number
DK456886A
Other languages
English (en)
Other versions
DK165356B (da
DK456886A (da
DK165356C (da
Inventor
Kazuhiro Shima
Takayuki Tsukada
Hirotane Kagawa
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK456886D0 publication Critical patent/DK456886D0/da
Publication of DK456886A publication Critical patent/DK456886A/da
Publication of DK165356B publication Critical patent/DK165356B/da
Application granted granted Critical
Publication of DK165356C publication Critical patent/DK165356C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK456886A 1985-09-25 1986-09-24 Stabile frysetoerrede praeparater af et anticancer platinkompleks DK165356C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60213180A JPH0665648B2 (ja) 1985-09-25 1985-09-25 白金系抗癌物質の安定な凍結真空乾燥製剤
JP21318085 1985-09-25

Publications (4)

Publication Number Publication Date
DK456886D0 true DK456886D0 (da) 1986-09-24
DK456886A DK456886A (da) 1987-03-26
DK165356B DK165356B (da) 1992-11-16
DK165356C DK165356C (da) 1993-04-05

Family

ID=16634867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK456886A DK165356C (da) 1985-09-25 1986-09-24 Stabile frysetoerrede praeparater af et anticancer platinkompleks

Country Status (9)

Country Link
US (1) US4767874A (da)
EP (1) EP0216362B1 (da)
JP (1) JPH0665648B2 (da)
KR (1) KR930010623B1 (da)
AU (1) AU593839B2 (da)
CA (1) CA1265745A (da)
DE (1) DE3669107D1 (da)
DK (1) DK165356C (da)
GB (1) GB2180839B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100877A (en) * 1986-05-21 1992-03-31 Kuraray Co., Ltd. Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same
EP0307827A3 (en) * 1987-09-15 1989-12-27 Kuraray Co., Ltd. Novel macromolecular complexes, process for producing same and medicinal use of such complexes
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
WO1990003402A1 (en) * 1988-09-27 1990-04-05 Kuraray Co., Ltd. Novel composite, process for its preparation and medicinal use thereof
DE3923270A1 (de) * 1989-07-14 1991-01-17 Medac Klinische Spezialpraep Wasserloesliche pharmazeutische metallocen-komplex-zusammensetzung
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6793912B2 (en) * 2001-08-20 2004-09-21 Transave Inc. Treatment of cancers by inhalation of stable platinum-containing formulations
CA2456746A1 (en) * 2001-08-20 2003-02-27 Transave, Inc. Method for treating lung cancers
CA2477979A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for treatment of intracellular infections
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
KR101301653B1 (ko) * 2002-10-29 2013-08-30 트랜세이브, 인코포레이티드 항감염제의 지속적인 방출
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
CN1976711A (zh) * 2004-03-18 2007-06-06 特兰萨维股份有限公司 通过吸入给药顺铂
CA2566174A1 (en) * 2004-05-21 2005-12-01 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
MX2007004955A (es) * 2004-11-08 2007-06-14 Transave Inc Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
US20060283742A1 (en) * 2005-06-16 2006-12-21 Canel Lightning Co. Ltd. Multi-lamp display packaging for lamps with collapsible lampshades
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056264A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190180A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
WO2007064658A2 (en) * 2005-11-30 2007-06-07 Transave, Inc. Safe and effective methods of administering therapeutic agents
CA2838111C (en) 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
CN102307568B (zh) * 2009-02-04 2014-12-24 帝斯曼知识产权资产管理有限公司 白藜芦醇组合物
CN101953805B (zh) * 2010-09-29 2012-05-30 贵州益佰制药股份有限公司 一种抗肿瘤药物制剂的制备方法
KR102277921B1 (ko) 2012-05-21 2021-07-14 인스메드 인코포레이티드 폐 감염을 치료하기 위한 시스템
JP2015530387A (ja) 2012-09-04 2015-10-15 エライゾン ファーマシューティカルズ， エルエルシー 脂質複合体化シスプラチンによる肺癌の再発防止
EP3581186A1 (en) 2012-11-29 2019-12-18 Insmed Incorporated Stabilized vancomycin formulations
CN103315967B (zh) * 2013-06-18 2015-09-30 江苏奥赛康药业股份有限公司 一种含奈达铂的冻干组合物、用途及其制备方法
CN103599079B (zh) * 2013-11-25 2016-06-08 江苏奥赛康药业股份有限公司 注射用洛铂药物组合物及其制备方法
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4598091A (en) * 1983-02-18 1986-07-01 Degussa Aktiengesellschaft (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds
JPS59222498A (ja) * 1983-06-01 1984-12-14 Shionogi & Co Ltd 新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
JPS617283A (ja) * 1984-06-20 1986-01-13 Shionogi & Co Ltd 新規白金錯体および抗悪性腫瘍剤
EP0167310B1 (en) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
DK500185A (da) * 1984-11-02 1986-05-03 Johnson Matthey Plc Oploeseliggjort platinforbindelse
US4737589A (en) * 1985-08-27 1988-04-12 Nippon Kayaku Kabushiki Kaisha Platinum Complexes
JPH0655752B2 (ja) * 1985-09-06 1994-07-27 三共株式会社 白金環状ウレア錯体

Also Published As

Publication number Publication date
JPS6272615A (ja) 1987-04-03
DE3669107D1 (de) 1990-04-05
JPH0665648B2 (ja) 1994-08-24
AU593839B2 (en) 1990-02-22
CA1265745A (en) 1990-02-13
EP0216362A2 (en) 1987-04-01
AU6310586A (en) 1987-03-26
DK165356B (da) 1992-11-16
GB2180839B (en) 1989-09-20
KR930010623B1 (ko) 1993-11-02
DK456886A (da) 1987-03-26
US4767874A (en) 1988-08-30
KR870002846A (ko) 1987-04-13
EP0216362B1 (en) 1990-02-28
GB8623117D0 (en) 1986-10-29
GB2180839A (en) 1987-04-08
DK165356C (da) 1993-04-05
EP0216362A3 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
DK456886D0 (da) Stabile frysetaerrede praeparater af et anticancer platinkompleks
DK376087A (da) Behandling af emulsioner
DK33287A (da) Imidazolanaloge af mevalonolacton og derivater deraf
DK246886A (da) Vandig parenteral oplaesning af t-pa
DK149988D0 (da) Stabile farmaceutiske praeparater
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
NO875232L (no) Stabile preparater av ricin-toksin-a-kjede og av rta-immunokonjugater og stabilisator-utsorteringsmetoder derav.
DK133786D0 (da) Praeparater
DK587A (da) Rensning af zirkonforbindelser
DK24986D0 (da) Praeparater
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK465487A (da) Anxiolytiske praeparater indeholdende dioxopiperidinderivater
IT8648188A0 (it) Preparazioni di coloranti stabili
KR870700350A (ko) 간염의 치료방법
DK466086D0 (da) Exogent syrnede antacidiumpraeparater
DK343686D0 (da) Paafoeringsindretning til paafoering af neglelak
DK105089A (da) Fremstilling af bis(amin-holdige)benzendioler
BR8504188A (pt) Preparacao de terpinen-4-ois
DK510785A (da) Oploesning til behandling af taender
BR8501438A (pt) Conjunto de campos cirurgicos
DK333587D0 (da) Anvendelse af pyridinderivater
KR860005771A (ko) 4-플루오로페놀의 제법
DK465886D0 (da) Formular til behandling af patentansaegning og fremgangsmaade til fremstilling af samme
BR6500318U (pt) Metodo de jogos desdobrados
RO93833A2 (ro) Solutie antiacneica si antiseboreica

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK